Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Seer Q1 2026 Earnings Call - Revenue Misses Amid Academic Funding Slump, But Biobank Momentum and IP Defense Signal Long-Term Play
Seer reported a sharp Q1 2026 revenue decline to $2.8 million, driven by a prolonged slump in academic and government funding, lumpy service project timing, and increased competition from lower-priced...
- Q1 2026 total revenue fell 33% year-over-year to $2.8 million, missing expectations due to depressed academic funding, competitive pressure from inferior imitators, and a lumpy service pipeline that lacked a major Q1 project.
- Management reaffirmed full-year 2026 revenue guidance of $16 million to $18 million, projecting approximately 3% growth at the midpoint over 2025, citing a 9-to-12-month lag in consumable reorders from last year's strong instrument install base.
- Operating expenses were aggressively cut to $18.2 million, a $4.6 million year-over-year reduction, driven by lower employee compensation and professional services costs, demonstrating strict capital discipline despite the revenue headwinds.
- +7 more takeaways
Shoulder Innovations Q1 2026 Earnings Call - Revenue Surges 65% as New Product Launches and Commercial Execution Drive Upward Guidance
Shoulder Innovations delivered a blistering start to 2026 with first-quarter net revenue jumping 65% year-over-year to $16.7 million, fueled by aggressive commercial execution and successful new produ...
- Revenue accelerated to $16.7 million in Q1 2026, representing a 65% year-over-year increase and a 16% sequential jump, demonstrating strong momentum into the new fiscal year.
- Full-year 2026 revenue guidance was raised to $65–$68 million, reflecting 37–44% growth over 2025 and signaling management's high conviction in sustained commercial execution.
- Gross margins remained robust at 77.7%, up from 76.9% in the prior year, driven by improved average selling prices and the early benefits of cost-reduction initiatives.
- +7 more takeaways
ClearPoint Neuro Q1 2026 Earnings Call - 43% Revenue Growth Driven by IRRAS Acquisition and Record $12.1M Top Line
ClearPoint Neuro delivered a strong first quarter of 2026, reporting record revenue of $12.1 million, a 43% increase year-over-year. The growth was fueled by a 25% organic expansion in device sales an...
- Revenue surged 43% year-over-year to a record $12.1 million, driven by 25% organic device growth and the full contribution of the IRRAS acquisition.
- Gross margin expanded to 64%, up 4 percentage points from Q1 2025, primarily due to lower excess and obsolete inventory reserves.
- IRRAflow integration is proceeding smoothly, adding a dual-lumen catheter that extends brain access capabilities and addresses a portfolio gap.
- +7 more takeaways
Fluent Q1 2026 Earnings Call - Commerce Media Surges to 58% of Revenue as Company Transforms
Fluent is executing a decisive pivot from a legacy marketplace model to a high-growth Commerce Media platform. The company’s Commerce Media Solutions segment grew 104% year-over-year in Q1 2026, captu...
- Commerce Media Solutions revenue surged 104% year-over-year to $25.9 million, representing 58% of total consolidated revenue, up from just 23% a year prior.
- Total consolidated revenue fell 19% to $44.9 million, but this primarily reflects the divestiture of Call Solutions; continuing business revenue declined only 3% year-over-year.
- Gross profit in Commerce Media Solutions grew 78% year-over-year to $5.0 million, though management expects margins to return to the mid-20s as early-term incentives roll off throughout 2026.
- +7 more takeaways
GrabAGun Digital Holdings Q1 2026 Earnings Call - Margin Expansion and PEW Logistics Launch Signal a Structural Shift in Firearm Commerce
GrabAGun Digital Holdings delivered a quarter that defies the broader industry's stagnation. Revenue grew 11.1% to $25.9 million while adjusted NICS checks rose a mere 1.6%. Management attributes this...
- Revenue grew 11.1% year-over-year to $25.9 million, significantly outpacing the 1.6% rise in adjusted NICS background checks, signaling aggressive market share gains.
- Firearms product sales rose 10.5% to $21.7 million, driven by favorable product mix, AI-powered pricing, and expanded marketing capabilities.
- Gross margin expanded 107 basis points to 10.7% of net sales, reflecting a shift toward higher-margin firearms categories and improved pricing optimization.
- +7 more takeaways
Snail Inc Q1 2026 Earnings Call - Revenue Surges 35% as AAA Pipeline and Stablecoin Launch Gaining Traction
Snail Inc reported a sharp turnaround in Q1 2026, with net revenue jumping 35.7% to $27.3 million and net income flipping to a $2.1 million profit from a prior-year loss. The lift came from strong ARK...
- Net revenue rose 35.7% year-over-year to $27.3 million, driven by a $4.2 million increase in ARK: Survival Ascended sales, a $2.1 million rise in Bellwright revenue, and $2.5 million in deferred revenue recognized.
- Net income flipped to a $2.1 million profit from a $1.9 million loss in the prior year, with EBITDA surging 173.3% to $2.4 million from a $3.2 million loss.
- Total units sold jumped 42.6% to 2.2 million, with ARK franchise sales adding 500,000 units and Bellwright contributing 200,000 units, supported by the Steam Winter event and the Lost Colony DLC.
- +7 more takeaways
Talphera Q1 2026 Earnings Call - Niyad NEPHRO Study Exceeds 50% Enrollment Milestone, PMA Targeted for 2027
Talphera reported strong progress in its Phase 2 NEPHRO study for Niyad, a potential regional anticoagulant for CRRT, having surpassed the 50% enrollment milestone with over 90% of patients enrolled a...
- Talphera has exceeded the 50% enrollment milestone in its NEPHRO study for Niyad, with over 90% of patients enrolled across its 12 active sites.
- The company is on track to complete enrollment in the NEPHRO CRRT study in 2026 and file a PMA for potential FDA approval of Niyad in 2027.
- Talphera closed a $4.1 million financing tranche in Q1 2026, bringing its cash balance to $21.1 million as of March 31, 2026.
- +7 more takeaways
QT Imaging Holdings Q1 2026 Earnings Call - Revenue Surges 133% as Scanner Shipments Double and Debt Maturity Extended
QT Imaging Holdings reported a sharp revenue jump in Q1 2026, doubling its scanner shipments to 13 units and driving revenue up 133% year-over-year to $6.5 million. The company is successfully transit...
- Revenue surged 133% year-over-year to $6.5 million in Q1 2026, driven primarily by a doubling of scanner shipments from 6 to 13 units.
- Net loss narrowed significantly to $3.4 million compared to $11.1 million in Q1 2025, reflecting improved operational leverage despite higher costs.
- Gross margin compressed to 41% from 65% in the prior year quarter, as higher hardware shipment volumes increased cost of revenue to $3.9 million.
- +9 more takeaways
Bionano Genomics Q1 2026 Earnings Call - Reimbursement Wins and Cash Burn Reality Check
Bionano Genomics reported a Q1 2026 revenue of $6.7 million, driven by a 20% jump in consumable sales and a record 17% year-over-year increase in flow cell volume. The company’s strategic pivot toward...
- Q1 2026 revenue reached $6.7 million, up 4% year-over-year and at the high end of guidance, with consumable sales driving a 20% year-over-year increase to $3.9 million.
- Flow cell volume hit a record 8,178 units in Q1, up 17% year-over-year, with existing customer usage rising 21% after removing new system sales.
- Adjusted gross margin expanded to 49.9% in Q1 2026, up from 46% in Q1 2025, reflecting operational efficiencies and a shift toward higher-margin recurring revenue streams.
- +7 more takeaways
Wrap Technologies Q1 2026 Earnings Call - Revenue Jumps 45% as Product Sales Surge 186% on BolaWrap Adoption
Wrap Technologies delivered a quarter that finally shows the non-lethal response business converting from concept to cash. Revenue grew 45% year-over-year to $1.1 million, driven by an 186% spike in p...
- Total revenue grew 45% year-over-year to $1.1 million, with product sales surging 186% to $0.9 million as BolaWrap 150 demand accelerates.
- Recurring revenue streams are maturing, with cassettes, consumables, and software subscriptions growing alongside the expanding installed base of devices.
- Gross margin compressed to 62% from 78% due to a temporary shift toward lower-margin hardware sales, though management expects improvement as software subscriptions scale.
- +7 more takeaways